Related Experiment Video
Updated: Aug 5, 2026

06:12
Inducing Acute Liver Injury in Rats via Carbon Tetrachloride (CCl4) Exposure Through an Orogastric Tube
Published on: April 28, 2020
Casticin Alleviates Acetaminophen-Induced Acute Liver Injury by Modulating the TLR4/MyD88/TRAF6/NF-κB Signaling
Salman H Alotaibi1, Mahmoud M Samaha1, Manar G Helal1
1Department of Pharmacology and Toxicology, Faculty of Pharmacy, Mansoura University, Mansoura 35516, Egypt.
Pharmaceuticals (Basel, Switzerland)
|July 28, 2026
Summary
Casticin, a natural flavonoid, protects the liver from acetaminophen overdose by reducing oxidative stress and inhibiting the TLR4 signaling pathway. This study demonstrates its potential as a protective agent against drug-induced liver injury.
Area of Science:
- Pharmacology and Toxicology
- Natural Product Chemistry
- Immunology
Background:
- Acetaminophen (APAP) overdose is a leading cause of acute liver injury (ALI), characterized by oxidative stress and innate immune activation.
- Casticin, a flavonoid, possesses known antioxidant and anti-inflammatory properties.
- The toll-like receptor 4 (TLR4)/myeloid differentiation primary response 88 (MyD88)/tumor necrosis factor receptor-associated factor 6 (TRAF6)/nuclear factor kappa B (NF-κB) pathway is implicated in APAP-induced liver damage.
Purpose of the Study:
- To investigate the protective effects of casticin against APAP-induced hepatotoxicity in a mouse model.
- To elucidate the role of casticin in modulating the TLR4/MyD88/TRAF6/NF-κB signaling pathway during APAP overdose.
Main Methods:
- Establishment of APAP-induced ALI in mice, with groups receiving casticin (low and high dose) or N-acetylcysteine (NAC) as a control.
- Administration of casticin for three days prior to APAP to assess preventive potential.
- Biochemical assays (ALT, AST, ALP), histological examination, lipid peroxidation assessment, antioxidant status evaluation, and molecular analyses (Western blotting, ELISA, qPCR, immunohistochemistry) to measure pathway component and cytokine levels.
Main Results:
- APAP overdose significantly increased liver injury markers (ALT, AST, ALP), hepatic architecture deterioration, lipid peroxidation, and oxidative stress.
- APAP elevated pro-inflammatory cytokines (TNF-α, IL-6), decreased IL-10, and upregulated key signaling molecules (TLR4, MyD88, TRAF6, NF-κB p65).
- Casticin treatment dose-dependently ameliorated these APAP-induced effects, reducing liver damage and suppressing the TLR4 signaling pathway, with efficacy comparable to NAC.
Conclusions:
- Casticin demonstrates significant hepatoprotective effects against APAP-induced acute liver injury.
- The protective mechanism involves the suppression of oxidative stress and the inhibition of the TLR4/MyD88/TRAF6/NF-κB inflammatory signaling cascade.
- Casticin holds promise as a preventive agent for acetaminophen-induced hepatotoxicity.
Related Concept Videos
NF-κB-dependent Signaling Pathway
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Acute Inflammation I: Inflammatory Response
Acute inflammation is a rapid, short-lived physiological response to tissue injury or infection, designed to eliminate harmful agents and initiate repair. This tightly regulated process typically lasts from minutes to several days and is triggered by factors such as microbial invasion, physical trauma, or chemical injury.Recognition and Mediator ReleaseThe inflammatory response begins when resident immune cells—such as mast cells, macrophages, and dendritic cells—detect damage-associated...